Related Experiment Video
Updated: Jul 8, 2026

Microfluidic Tools for Probing Fungal-Microbial Interactions at the Cellular Level
Published on: June 23, 2022
Will resistance in fungi emerge on a scale similar to that seen in bacteria?
1Institute of Medical Microbiology and Hygiene, University Clinic Mannheim, University of Heidelberg, 68167 Mannheim, Germany. herbert.hof@imh.ma.uni-heidelberg.de
Abstract:
Growing numbers of patients receive azoles as prophylaxis or treatment for invasive fungal infections, begging the question of whether emergence of resistance will occur, as has been seen with bacteria. This review examines resistance pathways shared by bacteria and fungi, including alteration and overproduction of drug targets, changes in biosynthetic pathways, and enhanced drug efflux, and assesses whether such commonalities predict increased resistance to azoles. Important differences exist between the two kingdoms, including little, if any, horizontal transfer of extrachromosomal material across fungal species and a longer fungal generation time, thereby slowing vertical transfer of mutant traits. Further, no enzymatic modulation or inactivation of azoles has been reported in fungi. The newer broad-spectrum azoles posaconazole and voriconazole are active against the vast majority of yeasts and moulds and are likely to prevent the emergence of inherently resistant strains. Therefore, the likelihood for an explosion of fungal resistance is relatively low.
Insights
Fungal resistance to azoles is unlikely to surge despite shared resistance pathways with bacteria. Differences in fungal biology and newer broad-spectrum azoles like posaconazole and voriconazole suggest low resistance emergence risk.
Area of Science:
- Mycology
- Antimicrobial Resistance
- Pharmacology
Background:
- Increasing use of azole antifungals for invasive fungal infections necessitates evaluating resistance emergence.
- Bacterial resistance to antibiotics provides a comparative model for potential fungal resistance.
Purpose of the Study:
- To review shared resistance mechanisms between bacteria and fungi.
- To assess the likelihood of azole antifungal resistance in fungi.
Main Methods:
- Comparative analysis of bacterial and fungal resistance pathways.
- Examination of genetic transfer mechanisms and drug target modifications.
- Review of azole drug properties and their activity spectrum.
Main Results:
- Shared resistance pathways include target alteration, overproduction, altered biosynthesis, and efflux pumps.
- Fungi exhibit limited horizontal gene transfer and longer generation times, slowing resistance spread.
- No enzymatic inactivation of azoles has been reported in fungi.
- Broad-spectrum azoles (posaconazole, voriconazole) are effective against most yeasts and molds.
Conclusions:
- Despite shared mechanisms, significant biological differences between fungi and bacteria suggest a low probability of widespread azole resistance.
- Newer azoles are likely to prevent the emergence of inherently resistant fungal strains.
Related Concept Videos
Overview of Fungi
Fungal Group Zygomycota
Development of Antibiotic Resistance
Fungal Phylum Ascomycota
Microbial Interactions: Cooperation
Fungal Phylum Basidiomycota

